Topic: MS

Application to FDA for first-line natalizumab

March 13, 2013  

Vitamin D and MS: conflicting evidence of clinical benefit

February 27, 2013  

RIS: what are the risk factors for CIS/MS?

February 13, 2013  

The Year in (P)review – MS 2013 – Is the Injectable Era (almost) Over?

January 31, 2013  

RIS: what are the risk factors for CIS/MS?

December 26, 2012  

Neuroprotection: This is your brain on tea

December 5, 2012  

FDA delays review of alemtuzumab

November 7, 2012  

Aubade for Aubagio: FDA approves teriflunomide in RRMS

October 24, 2012  

BG-12: Updated data from phase III studies

August 29, 2012  

What is the optimal dosing of natalizumab?

July 25, 2012